Showing 1 - 20 results of 2,020 for search '"Neoplasms drug therapy"', query time: 1.13s Refine Results
1
Academic Journal
2
Academic Journal
3
Academic Journal
4
Academic Journal
5
Academic Journal
6
Academic Journal
7
Academic Journal
8
Academic Journal
9
Academic Journal
10

Source: Lancet oncology

File Description: 2 full-text file(s): application/pdf; application/pdf

11

Source: Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 157, 47-55., Ireland. (2021).

12
Academic Journal
13
Academic Journal
14

Contributors: Oncology, CCA - Treatment and quality of life

Source: lancet oncology, 22(5), 665-677. Lancet Publishing Group
Andre, T, Amonkar, M, Norquist, J M, Shiu, K-K, Kim, T W, Jensen, B V, Jensen, L H, Punt, C J A, Smith, D, Garcia-Carbonero, R, Sevilla, I, De La Fouchardiere, C, Rivera, F, Elez, E, Diaz, L A, Yoshino, T, Van Cutsem, E, Yang, P, Farooqui, M & Le, D T 2021, ' Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177) : an open-label, randomised, phase 3 trial ', The Lancet Oncology, vol. 22, no. 5, pp. 665-677 . https://doi.org/10.1016/S1470-2045(21)00064-4

15
16
17

Contributors: Hubrecht Institute for Developmental Biology and Stem Cell Research

Source: Nature Communications, Vol 11, Iss 1, Pp 1-13 (2020)
Nature Communications, 11(1). Nature Publishing Group
Nature Communications

18
19

Source: Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
Alves, C L, Ehmsen, S, Terp, M G, Portman, N, Tuttolomondo, M, Gammelgaard, O L, Hundebøl, M F, Kaminska, K, Johansen, L E, Bak, M, Honeth, G, Bosch, A, Lim, E & Ditzel, H J 2021, ' Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer ', Nature Communications, vol. 12, 5112 . https://doi.org/10.1038/s41467-021-25422-9

20